Treatment of intestinal dysbacteriosis with Megabact

The gut microbiome is represented by more than 400 species of bacteria. There are more microorganisms in the gut than there are cells in the human body. Bacteria play a very important role: they help digest food, protect against pathogens, and synthesize vitamins.

Imbalance of the microbiota (dysbiosis or dysbacteriosis) can lead not only to the appearance of unpleasant symptoms, but also to the development of serious diseases. Factors that can provoke dysbacteriosis include:

• uncontrolled use of antibiotics;
• consumption of animal products treated with antibiotics;
• unhealthy diet (including lack of fiber in the diet);
• alcohol abuse;
• undergoing chemotherapy or radiation therapy.

The most common signs of dysbacteriosis are: abdominal pain, bloating, cramps, diarrhea, constipation, heartburn. Some people have: food intolerance, fatigue, low mood, joint pain, skin rashes.

If dysbacteriosis is not treated, it can lead to the development of a number of serious diseases, such as:

• inflammatory bowel disease (ulcerative colitis);
• irritable bowel syndrome;
• syndrome of increased intestinal permeability (leaky gut syndrome);
• eczema, dermatitis;
• metabolic syndrome;
• type 2 diabetes;
• rheumatoid arthritis;
• Parkinson’s disease, dementia;
• depression, anxiety;
• rectal cancer;
• obesity.

There is a wealth of scientific evidence linking gut dysbiosis with the development of serious diseases. Therefore, the treatment of this condition has recently received more and more attention.

Megabact is a unique drug for intestinal dysbiosis

The composition of the Megabact agent includes live microorganisms in an increased number of microbial units. The components of the drug exhibit high antagonistic activity against pathogens of intestinal infections, such as Salmonella, Shigella, enteropathogenic E. coli, Proteus, Campylobacter, Yersinia enterocolitica, Yersinia pseudotuberculosis, Staphylococcus, Candida, including polydrug resistant.

Due to the resistance to the acidic environment of the stomach, bacterial spores, which are part of Megabact, enter the intestine unchanged, where they turn into vegetative cells.

Bacteria exhibit antimicrobial activity, which is associated primarily with the production of almost 200 antibiotic-like substances. Also strains that are part of Megabact:

• actively produce enzyme complexes that stimulate and regulate digestion;
• contribute to better absorption of food, amino acids, including essential ones;
• stimulate protective reactions of the macroorganism.

Megabact creates conditions for the restoration of individual physiological intestinal microbiota due to:

• elimination (removal) from the intestine of pathogenic and conditionally pathogenic bacteria, fungal flora;
• positive effect on the state of general and local immunity, cytoprotective properties of the intestinal mucosal barrier.

Treatment with the drug contributes to the normalization of the qualitative and quantitative composition of the individual physiological intestinal microbiota of a healthy person.

Indications for use

Megabact is recommended as a dietary supplement to the diet:

• to normalize intestinal microbiocenosis in case of its violation;
• in cases associated with the occurrence of diarrhea, constipation, bloating, which arose, in particular, against the background of antibiotic therapy;
• to reduce the allergenicity of products that contain gluten;
• to reduce the allergenicity of products that contain cow’s milk proteins;
• to stimulate the growth of lactobacilli and bifidobacteria;
• with intestinal destruction after radio- and chemotherapy.